Dramatic improvement of generalized prurigo nodularis with dupilumab

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):e303-e304. doi: 10.1111/jdv.15584. Epub 2019 May 8.

Authors

A Calugareanu¹, M Jachiet^{1

2}, C Lepelletier^{1

2}, A De Masson^{1

2}, M Rybojad^{1

2}, M Bagot^{1

2}, J D Bouaziz^{1

2}

Affiliations

¹ Dermatology Department, Saint-Louis Hospital, APHP, Paris, France.
² Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France.

PMID: 30893496
DOI: 10.1111/jdv.15584

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / pharmacology
Antibodies, Monoclonal, Humanized / therapeutic use*
Female
Humans
Interleukin-4 Receptor alpha Subunit / antagonists & inhibitors*
Prurigo / drug therapy*
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Interleukin-4 Receptor alpha Subunit
dupilumab